KCNQ1 and Pitt-Hopkins syndrome: The Prestwick chemical library was screened to identify 55 Kv7.1 and 93 Nav1.8 inhibitors, which we identified as lead therapeutics for potential PTHS intervention.60 We then compared our results to a Bayesian ML model’s prediction in Assay Central with the Bayesian ML model identifying 35 Kv7.1 and 64 Nav1.8 inhibitors.